Retrovirus from the HIV type O and its use (MVP-2901/94)

US6548635B1 · kind B1 · utility

Assignee

• Dade Behring Marburg GmbH · DE

Inventors

• Hans-Peter Hauser · Marburg, DE
• Stefan Knapp · Marburg, DE
• Stefan Brust · Marburg, DE
• Lutz G. Gürtler · Munich, DE
• Josef Eberle · Freising, DE
• Lazare Kaptue · Brüggen, DE
• Leopold Zekeng · Brüggen, DE

Key dates

• Filing date: Jul 6, 2000
• Grant date: Apr 15, 2003
• Expiry date: Jul 6, 2020

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S530/812
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

A novel HIV type O immunodeficiency virus is disclosed which has the designation MVP-2901/94 and which has been deposited with the European Collection of Animal Cell Cultures (ECACC) under No. V 950121601. The characteristic antigens which can be obtained from the virus and which can be employed for detecting antibodies against retroviruses which are associated with immunodeficiency diseases are also disclosed, as are the partial DNA and amino acid sequences of the virus.